EWM

Essex Woodlands Management Portfolio holdings

AUM $279M
1-Year Return 29.39%
This Quarter Return
+17.89%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$431M
AUM Growth
-$26.3M
Cap. Flow
-$37.4M
Cap. Flow %
-8.68%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

1
EYPT icon
EyePoint Pharmaceuticals
EYPT
+$35.1M

Top Sells

1
ABMD
Abiomed Inc
ABMD
+$58.7M
2
RVNC
Revance Therapeutics, Inc.
RVNC
+$13.7M

Sector Composition

1 Healthcare 96.84%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AXGN icon
1
Axogen
AXGN
$755M
$186M 43.3%
3,711,111
– –
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
$91.7M 21.3%
3,342,047
-500,000
-13% -$13.7M
CORI
3
DELISTED
Corium International, Inc.
CORI
$74.9M 17.4%
9,353,304
– –
EYPT icon
4
EyePoint Pharmaceuticals
EYPT
$944M
$53M 12.3%
2,547,039
+1,686,407
+196% +$35.1M
ELGX
5
DELISTED
Endologix Inc
ELGX
$13.6M 3.16%
125,747
– –
MNOV icon
6
MediciNova
MNOV
$59.8M
$9.32M 2.16%
1,170,370
– –
GYRE icon
7
Gyre Therapeutics
GYRE
$706M
$933K 0.22%
10,483
– –
ACUR
8
DELISTED
Acura Pharmaceuticals Inc
ACUR
$704K 0.16%
1,956,397
– –
ABMD
9
DELISTED
Abiomed Inc
ABMD
– –
-201,818
Closed -$58.7M